Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease

ClinicalTrials.gov ID: NCT06773962

Public ClinicalTrials.gov record NCT06773962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 2:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of TB006 in Participants With Parkinson's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objectives of this study are to assess the efficacy of TB006 in improving motor function and to assess the safety of TB006 in participants with Parkinson's Disease (PD).

Study identification

NCT ID
NCT06773962
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
TrueBinding, Inc.
Industry
Enrollment
62 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 20, 2025 (Actual)
Primary completion
Nov 28, 2026 (Estimated)
Completion
Nov 28, 2026 (Estimated)
Last update posted
Apr 23, 2026

2025 – 2026

United States locations

U.S. sites
14
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
Parkinson's Research Centers of America - Orange County Aliso Viejo California 92656 —
Parkinson's Research Centers of America - Palo Alto Palo Alto California 94301 —
CenExel Rocky Mountain Clinical Research Englewood Colorado 80113 —
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486 —
University of Miami Miami Florida 33136 —
University of South Florida Parkinson's and Movement Disorders Center Tampa Florida 33613 —
Consultants in Neurology, Ltd Northbrook Illinois 60062 —
Josephson Wallack Munshower Neurology - Southeast Indianapolis Indiana 46256 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Quest Research Institute Farmington Hills Michigan 48334 —
Parkinson's Research Centers of America - Long Island Commack New York 11725 —
NYU Langone Health Patchogue New York 11772 —
Oregon Health & Science University Portland Oregon 97239 —
Central Texas Neurology Consultants Round Rock Texas 78681 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06773962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06773962 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →